World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02657148
Date of registration: 21/09/2015
Prospective Registration: Yes
Primary sponsor: University of Pittsburgh
Public title: Immediate Postpartum Nexplanon Placement in Opioid Dependent Women
Scientific title: A Prospective Observational Clinical Trial to Compare the Effect of Immediate Postpartum Nexplanon Placement Versus Standard Postpartum Contraceptive Care on Consistent Contraceptive Use and Rapid Repeat Pregnancy in Opioid Dependent Women.
Date of first enrolment: May 2016
Target sample size: 200
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02657148
Study type:  Observational
Study design:   
Phase: 
Countries of recruitment
United States
Contacts
Name:     Elizabeth E Krans, MD, MSc
Address: 
Telephone:
Email:
Affiliation:  University of Pittsburgh
Key inclusion & exclusion criteria

Inclusion Criteria: Pregnant women, 18 years or older, who meet DSM-V criteria for opioid
use disorder confirmed by diagnostic coding in the patient's medical record and/or urinary
toxicology screen (UDS) and who plan to deliver at the study site hospital, Magee-Womens
Hospital of UPMC (MWH-UPMC).

Exclusion Criteria: Women who have contraindications to etonogestrel use, intrauterine
fetal demise or stillbirth, and/or who do not plan to deliver at MWH-UPMC.



Age minimum: 18 Years
Age maximum: N/A
Gender: Female
Health Condition(s) or Problem(s) studied
Sexual Behavior
Contraceptive Behavior
Pregnancy
Opiate Addiction
Intervention(s)
Drug: Nexplanon (etonogestrel contraceptive implant)
Drug: Standard postpartum contraceptive care
Primary Outcome(s)
Consistent contraception [Time Frame: 12 months postpartum]
Secondary Outcome(s)
High-risk sexual behavior [Time Frame: 12 months]
Breastfeeding initiation [Time Frame: 12 months postpartum]
Infant weight gain [Time Frame: 12 months]
Infant development [Time Frame: 12 months]
Postpartum depression [Time Frame: 12 months postpartum]
Rapid, repeat pregnancy [Time Frame: 12 months postpartum]
Secondary ID(s)
IIS#53505
PRO15070357
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Merck Sharp & Dohme Corp.
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history